Matthew Sykes
Stock Analyst at Goldman Sachs
(3.53)
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
FTRE Fortrea Holdings | Maintains: Neutral | 7 5 | 10.1 | -50.5% | 4 | May 14, 2025 | |
CTKB Cytek Biosciences | Maintains: Sell | 4 3 | 3.94 | -23.86% | 9 | May 12, 2025 | |
TXG 10x Genomics | Maintains: Sell | 8 7 | 12.64 | -48.58% | 7 | May 12, 2025 | |
BRKR Bruker | Maintains: Neutral | 50 45 | 30.91 | 45.58% | 5 | May 8, 2025 | |
MYGN Myriad Genetics | Maintains: Buy | 14 8 | 7.24 | 10.5% | 12 | May 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 55 48 | 25.31 | 89.65% | 10 | May 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 14 17 | 16.05 | 5.92% | 1 | May 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 180 160 | 175 | -8.57% | 4 | May 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 15 10 | 7.96 | 25.63% | 8 | Apr 30, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 140 125 | 82.88 | 50.82% | 2 | Apr 29, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 23 14 | 12.31 | 13.73% | 6 | Apr 29, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 260 240 | 190.07 | 26.27% | 5 | Apr 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 34 26 | 13.53 | 92.17% | 10 | Apr 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 190 170 | 152.92 | 11.17% | 4 | Mar 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 49 56 | 54.9 | 2% | 13 | Feb 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 70 80 | 123.97 | -35.47% | 11 | Feb 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 2 2 | 1.17 | 28.21% | 5 | Feb 18, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 160 190 | 168.51 | 12.75% | 13 | Jan 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 3 2 | 0.72 | 143.06% | 5 | Dec 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 7 5 | 2.67 | 59.18% | 10 | Dec 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 38 37 | 30.88 | 19.82% | 5 | Dec 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 75 65 | 53.94 | 20.5% | 12 | Nov 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 280 250 | 187.2 | 33.55% | 2 | Nov 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 23 7 | 20.01 | -67.52% | 11 | Jul 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 35 24 | 4.81 | 398.96% | 13 | Jul 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 1150 1300 | 1259.39 | 3.22% | 5 | Jul 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 32 12 | 9.99 | 20.12% | 6 | Jul 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 550 640 | 479.5 | 33.47% | 4 | Apr 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 128 145 | n/a | n/a | 4 | Dec 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | n/a | n/a | n/a | 3 | Dec 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 1 1 | n/a | n/a | 6 | Nov 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 1 1 | n/a | n/a | 8 | Oct 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 1 1 | n/a | n/a | 2 | May 17, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 16 18 | 26.08 | -30.98% | 5 | Feb 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 3 1 | n/a | n/a | 2 | Dec 7, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 200 175 | 115.24 | 51.86% | 3 | Jul 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 120 60 | n/a | n/a | 4 | Apr 19, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 6 4 | 2.43 | 64.61% | 4 | Apr 13, 2022 |